Applied Tissue Technologies Acquired by New Horizon — Healthcare M&A

New Horizon Medical Solutions, a Las Vegas-based strategic buyer in healthcare wound care, announced it has acquired Applied Tissue Technologies. The deal is structured as an add-on acquisition and is intended to broaden New Horizon’s wound care portfolio by adding Applied Tissue’s transparent negative-pressure wound therapy (NPWT) device along with a micrografting kit. The acquisition expands New Horizon’s existing focus on advanced wound care tools, including biologics and skin substitutes, as well as related workflow and technology integration services.

Applied Tissue Technologies is known for proprietary wound-healing technologies designed to support faster recovery and improved clinical outcomes. Its NPWT offering and micrografting capabilities align with broader market demand for advanced wound care solutions that can enhance donor-to-coverage efficiency and support clinicians in complex wound management. For New Horizon, integrating these device and kit capabilities strengthens its position as a provider of both products and supporting services for wound care delivery.

Financial terms were not disclosed. The announcement indicates the transaction is in the announced stage, with Applied Tissue’s wound care technologies expected to be incorporated into New Horizon’s portfolio.